PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

Published:2015-01-22 Issue:4 Volume:372 Page:311-319
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Ansell Stephen M.,Lesokhin Alexander M.,Borrello Ivan,Halwani Ahmad,Scott Emma C.,Gutierrez Martin,Schuster Stephen J.,Millenson Michael M.,Cattry Deepika,Freeman Gordon J.,Rodig Scott J.,Chapuy Bjoern,Ligon Azra H.,Zhu Lili,Grosso Joseph F.,Kim Su Young,Timmerman John M.,Shipp Margaret A.,Armand Philippe

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1411087

Cited by 3050 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brusatol improves the efficacy of an anti-mouse-PD-1 antibody via inhibiting programmed cell death 1 ligand 1 expression in a murine head and neck squamous cell carcinoma model;Archives of Oral Biology;2024-10

2. PD-L1 and PD-1 in immune regulation and their implications in blood cancers;Advances in Cancer Biology - Metastasis;2024-10

3. Current uses and resistance mechanisms of enzalutamide in prostate cancer treatment;Expert Review of Anticancer Therapy;2024-09-14

4. Barriers and opportunities in pancreatic cancer immunotherapy;npj Precision Oncology;2024-09-12

5. Clinical features, treatment, and outcome of nivolumab induced cholangitis;Immunopharmacology and Immunotoxicology;2024-09-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP